We are live on ! Find out more
QC

Quantessence Capital Portfolio holdings

AUM $20.5M
1-Year Est. Return 71.02%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$400M
AUM Growth
+$156M
Cap. Flow
+$166M
Cap. Flow %
41.53%
Top 10 Hldgs %
29.1%
Holding
490
New
266
Increased
41
Reduced
24
Closed
158

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$28.6M
2
XLC icon
State Street Communication Services Select Sector SPDR ETF
XLC
+$12.7M
3
PFE icon
Pfizer
PFE
+$11M
4
PDCO
Patterson Companies, Inc.
PDCO
+$10.2M
5
BECN
Beacon Roofing Supply, Inc.
BECN
+$9.88M

Top Sells

Rank Stock Value
1
IP icon
International Paper
IP
+$11.1M
2
IYR icon
iShares US Real Estate ETF
IYR
+$11.1M
3
META icon
Meta Platforms (Facebook)
META
+$7.23M
4
UMBF icon
UMB Financial
UMBF
+$6.83M
5
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$6.69M

Sector Composition

Rank Sector Weight
1 Healthcare 24.24%
2 Financials 15.91%
3 Technology 11.39%
4 Industrials 10.54%
5 Consumer Staples 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CURI icon
326
CuriosityStream
CURI
$139M
$47.2K 0.01%
+17,612
New +$42.8K
TARA icon
327
Protara Therapeutics
TARA
$226M
$43.4K 0.01%
+10,188
New +$45.5K
KRMD icon
328
KORU Medical Systems
KRMD
$176M
$41.8K 0.01%
+16,469
New +$61.2K
SVC
329
Service Properties Trust
SVC
$1.1B
$34.7K 0.01%
+2,660
New +$36K
RLAY icon
330
Relay Therapeutics
RLAY
$4.02B
$33.1K 0.01%
+12,650
New +$49.6K
IKT icon
331
Inhibikase Therapeutics
IKT
$366M
$28.5K 0.01%
+13,005
New +$32.7K
ZVIA icon
332
Zevia
ZVIA
$108M
$25.9K 0.01%
+11,973
New +$39.2K
A icon
333
Agilent Technologies
A
$39.1B
– –
-10,648
Closed -$1.43M
ABT icon
334
Abbott
ABT
$180B
– –
-4,383
Closed -$496K
ACN icon
335
Accenture
ACN
$89.9B
– –
-7,069
Closed -$2.49M
AMP icon
336
Ameriprise Financial
AMP
$46.8B
– –
-1,362
Closed -$725K
APTV icon
337
Aptiv
APTV
$12B
– –
-14,350
Closed -$868K
ASAN icon
338
Asana
ASAN
$1.58B
– –
-12,728
Closed -$258K
EFOR
339
Everforth Inc
EFOR
$845M
– –
-3,713
Closed -$309K
AU icon
340
AngloGold Ashanti
AU
$40.3B
– –
-143,404
Closed -$3.31M
AVGO icon
341
Broadcom
AVGO
$1.82T
– –
-12,169
Closed -$2.82M
BNY
342
Bank of New York Mellon
BNY
$108B
– –
-6,452
Closed -$496K
BKNG icon
343
Booking.com
BKNG
$138B
– –
-6,100
Closed -$1.21M
BLD
344
DELISTED
TopBuild
BLD
– –
-784
Closed -$244K
BLDR icon
345
Builders FirstSource
BLDR
$7.84B
– –
-1,446
Closed -$207K
BOX icon
346
Box
BOX
$4.02B
– –
-9,472
Closed -$299K
BWA icon
347
BorgWarner
BWA
$13.2B
– –
-7,539
Closed -$240K
BYD icon
348
Boyd Gaming
BYD
$6.47B
– –
-5,649
Closed -$410K
C icon
349
Citigroup
C
$222B
– –
-27,565
Closed -$1.94M
CAVA icon
350
CAVA Group
CAVA
$7.22B
– –
-9,979
Closed -$1.13M
12 13
14
15 16

Similar funds

FS
Financially Speaking Greenwood Village, Colorado $20.6M AUM 24.93% 1-Year Est. Return
BC
Bakala Capital Greenville, South Carolina $20.8M AUM 13.01% 1-Year Est. Return
HAM
Honeycomb Asset Management New York $19.4M AUM 25.86% 1-Year Est. Return
DP
Declaration Partners New York $21.8M AUM
SPC
Stone Point Capital Greenwich, Connecticut $21.9M AUM 47.18% 1-Year Est. Return
IW
Imprint Wealth Mount Pleasant, South Carolina $21.9M AUM
SRHG
Stone Ridge Holdings Group New York $19M AUM 8.85% 1-Year Est. Return
MPW
MGO Private Wealth Irvine, California $18.6M AUM 16.57% 1-Year Est. Return

Quantessence Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Quantessence Capital held 490 positions worth $400M, up 64% from $244M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Quantessence Capital deployed $166M of net new capital in Q1 2025, opening 266 new positions and adding to 41 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 229,788 shares worth $30.3M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 5.7% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares US Real Estate ETF, an estimated $11.1M trimmed.

  • Quantessence Capital's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 229,788 shares worth $30.3M.
  • Quantessence Capital added most to Beacon Roofing Supply, Inc. in Q1 2025, an estimated $9.88M increase.
  • Quantessence Capital's biggest Q1 2025 reduction was iShares US Real Estate ETF, cutting an estimated $11.1M.
  • Quantessence Capital fully exited International Paper in Q1 2025, selling an estimated $11.1M.
  • Quantessence Capital's ten largest holdings make up 29% of its $400M portfolio in Q1 2025.
  • Quantessence Capital opened 266 new positions and closed 158 in Q1 2025.
  • Quantessence Capital's portfolio value rose 64% quarter-over-quarter to $400M.

Based on Quantessence Capital's 13F filing for Q1 2025, filed 15 May 2025.